Antibodies 2013, 2(1), 82-92; doi:10.3390/antib2010082
Review

An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells

1 Department of Pharmacology, University of Minnesota, 210 Delaware Street Southeast Minneapolis, MN 55455, USA 2 Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, 425 East River Parkway Minneapolis, MN 55455, USA
* Author to whom correspondence should be addressed.
Received: 6 December 2012; in revised form: 19 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
(This article belongs to the Special Issue Recombinant Immunotoxins)
PDF Full-text Download PDF Full-Text [169 KB, uploaded 28 January 2013 13:21 CET]
Abstract: Targeting and killing specific cells discriminately has been the goal of targeted therapy dating back to the era of Paul Ehrlich. The discovery of cancer stem cells has caused a paradigm shift within the cancer field and provided an opportunity to use targeted therapies such as targeted toxins to bind and kill these cells selectively. A number of targeted toxins have been developed against recently identified cancer stem cell markers. In this review we discuss the development and current status of these exciting novel drugs and their potential use to combat drug-refractory relapse.
Keywords: cancer stem cells; targeted toxins; immunotoxins; CD133; EpCAM; CD123; CD44

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Waldron, N.N.; Vallera, D.A. An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies 2013, 2, 82-92.

AMA Style

Waldron NN, Vallera DA. An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies. 2013; 2(1):82-92.

Chicago/Turabian Style

Waldron, Nate N.; Vallera, Daniel A. 2013. "An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells." Antibodies 2, no. 1: 82-92.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert